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Peripheral blood lymphocytes from t3 patients with es- 
tablished insulin-dependent diabetes mellitus (IDDM) and 
2 prediabetic patients were examined for natural killer 
(NK) and antibody-dependent cellular cytotoxic activities 
(ADCC), lectin-dependent cellular cytotoxicity (LDCC), 
interferon- and interleukin-2-induced cytotoxicity, and 
concanavalin A-induced suppressor-cell activities in com- 
parison with age-matched normal controls. IDDM pa- 
tients demonstrated normal levels of NK and ADCC 
activities against K562 and antibody-coated SB target 
cells, respectively, compared to controls. IDDM patients 
showed normal levels of LDCC activity. Notable devia- 
tions from control values were, however, observed with 
diabetic lymphocytes in the following systems. Inter- 
feron- and interleukin-2-induced NK activities were sig- 
nificantly higher with IDDM lymphocytes than with con- 
trol cells. IDDM lymphocytes precultured with 
concanavalin A demonstrated lower NK and ADCC 
activities than control cells and manifested decreased 
suppressor effects on the NK activity of normal al- 
logeneic lymphocytes. Lymphocytes from one of two 
prediabetic patients showed increased NK, ADCC, and 
LDCC activities in comparison to controls. The increased 
interferon- and interleukin-2-induced enhancement of NK 
activity and reduced suppressor activity of lymphocytes 
from IDDM patients may be involved in the pathogenesis 
of the disease. 
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INTRODUCTION 
Recent evidence has suggested a role for autoim- 
mune mechanisms in the pathogenesis of insulin- 
dependent diabetes mellitus (IDDM). Support for 
this premise derives from several observations 
made in diabetic patients. Lymphocytic infiltration 
of pancreatic islets has been described in patients 
with IDDM (1). The presence of specific islet-cell 
antibodies has been noted generally during the early 
stages of disease (2, 4); these antibodies may exhibit 
complement-dependent cytotoxicity against islet 
cells (3). Increased numbers of functional T cells 
have been observed in the peripheral blood of 
IDDM patients (6) and some of these cells were 
"activated" T cells (5). Specific destruction of islet 
cells by immune lymphocytes from diabetic patients 
can occur in vitro (7), Finally, patients with IDDM 
can manifest delayed- and/or immediate-type 
hypersensitivity to insulin and pancreatic extracts 
(8, 9). 
Recent studies on natural killer (NK) and anti- 
body-dependent cellular cytotoxic (ADCC) effector 
cells have examined their role in immunologic sur- 
veillance against tumors and in the regulation of 
various immune reactions (10--12). The significance 
of NK and ADCC reactions and the mechanisms 
that control these functions have not previously 
been examined in patients with type I diabetes. The 
present studies were designed to investigate the NK 
and ADCC activities of lymphocytes from patients 
with IDDM and prediabetes in comparison with 
normals. Further, the immunoregulatory effects of 
diabetic lymphocytes precultured with and without 
concanavalin A (Con A) on the NK activities of 
lymphocytes from normal allogeneic donors were 
also examined. These studies demonstrate that pa- 
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tients with type I diabetes have normal ranges of 
NK and ADCC activities against tumor target cells. 
However, compared to healthy controls, diabetic 
lymphocytes showed decreased Con A-inducible 
suppressor-cell activity on the NK functions of 
normal allogeneic lymphocytes. 
MATERIALS AND METHODS 
Patients 
Thirteen white IDDM patients, six males and 
seven females, ranging in age from 17 to 37 years, 
with a disease duration of 1.5 to 23 years (mean, 
13.9 years), were investigated. All patients were 
receiving insulin at the time of study. Twelve of the 
13 patients were seronegative for cytoplasmic islet- 
cell antibodies (ICA) as determined by im- 
munofluorescence using fresh-frozen human blood 
group O pancreas as described (2). Two white 
prediabetic patients, a male aged 27 years and a 
female aged 25 years, were also examined. The 
diagnosis of prediabetes was based on strongly 
ICA-positive sera and a normal insulin response to 
IVGTT in the male and an abnormal OGTT with 
normal fasting and postprandial blood glucose in the 
female. 
Depletion of Adherent Cells 
PBMC were suspended in RPMI 1640 with 10% 
FCS and depleted of adherent cells by passage 
through a 7-mt column of Sephadex G-10 beads 
(Pharmacia Fine Chemicals, Piscataway, N J), 
equilibrated in the same medium. After 45 rain of 
incubation at 37°C, nonadherent peripheral blood 
lymphocytes (PBL) were eluted with 1 bed vol of 
medium at 37°C. Cell recovery was >70% of the 
total input and monocyte contamination as indi- 
cated by nonspecific esterase staining was <2%. 
Preparation of Target Cells 
The human erythroleukemia cell line, K562, was 
used as targets for NK cells in a 4-hr SlCr release 
assay. For the ADCC assay, we chose as targets an 
antibody-coated human B-cell leukemia line (SB) 
because of its resistance to NK activity. Target 
cells 'passaged for 48 hr were washed twice with 
CM. To 0.8-ml aliquots of CM containing 5 x 10 6 
tumor cells, 200 ixCi of 51Cr as sodium chromate 
(New England Nuclear, Boston, MA) was added. 
The cells were incubated at 37°C for 1 hr in a 
humidified atmosphere of 5% CO2 in air with inter- 
mittent shaking. Following incubation, the cells 
were washed three times with CM and resuspended 
to a concentration of 1 x 105 cells/ml. 
Controls 
A group of 15 age-matched, healthy, white vol- 
unteers of both sexes with no history of autoim- 
mune disease, allergy, or diabetes was investigated 
for comparison. 
Isolation of Lymphocytes 
Peripheral blood mononuclear cells (PBMC) were 
isolated from heparinized (20 U/ml) venous blood 
using a modified method of Boyum (13). Blood was 
diluted with an equal volume of normal saline and 
centrifuged at 400g for 30 rain at 18°C. The mono- 
nuclear-cell band was harvested, washed three 
times with saline, and resuspended in RPMI 1640 
medium, containing 25 mM Hepes buffer supple- 
mented with 10% heat-inactivated fetal calf serum 
(FCS) (GIBCO, Grand Island, NY), 80 p~g/ml 
gentamicin (Schering Corp., Kenilworth, N J), and 
300 ~xg fresh glutamine/ml (complete medium). 
Assay for NK Activity 
NK activity was measured in a direct 51Cr release 
assay as previously described (14). A fixed number 
of viable effector cells in CM was added to triplicate 
cultures of 51Cr-labeled targets in V-bottom micro- 
titration plates (CoStar, Cambridge, MA). After 
centrifugation at 40g for 2 rain, they were incubated 
at 37°C in a humidified atmosphere of 5% CO2 in air 
for 4 hr. At the end of incubation the plates were 
centrifuged at 400g for 10 rain and 100-~xl aliquots 
were removed from each well, transferred to glass 
tubes, and read in a Packard Model 593 gamma 
counter. Percentage cytotoxicity was calculated as 
follows: 
% cytotoxicity = 
experimental release - spontaneous release 
x 100, 
total release - spontaneous release 
where spontaneous release represents counts re- 
leased from control wells containing 1 x 104 target 
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cells, and total release represents counts obtained 
from an aliquot of I x 104 target cells. Cytotoxicity 
was also expressed as lytic units (LU) per 107 
effector cells, defined as the number of effector cells 
needed to yield 30% cytotoxicity of 1 x 104 target 
cells. LU were calculated by linear regression anal- 
ysis from a cytotoxicity curve using four different 
effector-to-target (E:T) cell ratios for each test as 
described by Kadish et al. (15). 
Assay for ADCC Activity 
ADCC activity was determined as previously 
described (14). Briefly, 50 txl of varying concentra- 
tions of effector cells was added to 50 Ixl of CM 
containing 51Cr-labeled SB target cells and 100 pol of 
a 2 x 10 -4  dilution of rabbit anti-SB antiserum 
previously found to yield maximum ADCC. Per- 
centage cytotoxicity was calculated as described 
above for NK activity with the following excep- 
tions. Spontaneous release represents counts re- 
leased in control wells containing effector cells, 
51Cr-labeled SB target cells, and medium without 
anti-SB antibody, and total release represents 
counts obtained in an aliquot of 1 x 104 labeled 
target cells. 
Lectin-Dependent Ceil-Mediated Cytotoxicity 
(LDCC) Assay 
The LDCC assay was carried out similarly to the 
NK assay except that NK-resistant SB cells were 
used as targets (16). Briefly, different numbers of 
target and effector cells were added to V-bottom 
microtitration plates, followed by phytohemag- 
glutinin-P (PHA; Difco Laboratories, Detroit, MI) 
at concentrations of I, 2.5, and 5 ~g/rnt to a final 
volume of 0.2 ml. The plates were incubated for 4 hr 
at 37°C in a humidified 5% CO2 in air incubator. 
Percentage LDCC activity was calculated as de- 
scribed for NK activity and was compared with 
cytotoxicity observed with control cultures contain- 
ing effector and target cells in the absence of PHA. 
Percentage cytotoxicity was calculated as follows: 
% cytotoxicity = 
experimental release - spontaneous release 
x 100, 
total release - spontaneous release 
where spontaneous release represents counts re- 
leased from control wells containing 1 x 10 4 target 
cells alone plus lectin, and total release represents 
counts obtained in an aliquot of 1 x 10 4 target cells. 
In te r f e ron  
Recombinant interferon-alpha (IFN) (specific act, 
- 1  × 108 U/mg protein) was a gift from Schering 
Corp., Bloomfield, NJ. IFN was diluted in RPMI 
1640 and stored at -70°C before use. The maximum 
NK augmenting dose was 250 U/ml as previously 
determined. 
Interleukin-2 (IL2) 
Commercially available IL2 (Electro-Nucleonics 
Labs, Inc., Silver Spring, MD) was diluted in RPMI 
1640 and stored at -70°C before use. IL2 was 
purified from human peripheral blood leukocytes by 
several chromatographic steps and is devoid of any 
lectin or IFN. A final concentration of 64 U/ml, the 
maximal NK augmenting dose as previously deter- 
mined, was used. 
In Vitro Generation of Suppressor Cells with 
Con A 
Total PBL were suspended in CM at a concen- 
tration of 4 x 10 6 cells/ml, to which Con A at a 
concentration of 30 jxg/ml was added. A duplicate 
set of cultures received CM without Con A as a 
control. All cultures were incubated in a humidified 
environment of 5% CO2 in air at 37°C for 48 hr. 
Cells were washed four times with saline and resus- 
pended in CM as described (17). Cell viability as 
determined by trypan blue dye exclusion was not 
affected by concentrations of -<30 ~xg Con A/ml and 
was found to be >70%. The viability was compara- 
ble with that of control cultures. Estimation of 
nonspecific esterase-positive cells was approxi- 
mately 10.5% in control cultures and about 6.0% in 
Con A-treated cultures. The percentage of 
phagocytic cells, as identified by ingestion of latex 
particles, was approximately 9% in control cultures 
and about 4.5% in Con A-treated cultures. 
Assay of Suppressor-Cell Activity 
In coculture experiments to measure suppressor- 
celt activity, PBL precultured with or without Con 
A were added to a mixture of effector and prelabel- 
ed target cells. The observed cytotoxicity demon- 
strated by the cell mixture was compared to the sum 
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of cytotoxicities shown by precultured PBL and 
effector cells when tested alone. In these mixing 
experiments the E:T cell ratio and suppressor-to- 
effector (S:E) cell ratio were maintained at 50:1 and 
I:1, respectively. All plates were treated as de- 
scribed for the cytotoxicity assay. Percentage sup- 
pression was calculated as detailed elsewhere (17) 
or, briefly, as follows: 
predicted cytotoxicity - 
observed cytotoxicity 
% suppression = x 100, 
predicted cytotoxicity 
where predicted cytotoxicity is calculated as the 
sum of the individual cytotoxicities of effector cells 
plus precultured PBL, and observed cytotoxicity is 
the cytotoxicity demonstrated by the mixture of 
effector and precultured PBL. Results are ex- 
pressed as mean values -+ SE. The statistical sig- 
nificance of differences in mean values was deter- 
mined using a single-tail Student t-test formula. 
RESULTS 
NK and ADCC Activities of Lymphocytes from 
IDDM Patients 
Figure 1A shows the NK activity of normal, 
diabetic, and prediabetic lymphocytes, at different 
E:T cell ratios. A total of 12 IDDM and 2 predi- 
abetic patients was compared with 12 normal con- 
trols at each E:T cell ratio. Diabetic patients man- 
ifested considerable variation in their NK activity at 
all E:T cell ratios. At a 50:1 E:T cell ratio, diabetic 
patients showed cytotoxicity ranging from 3 to 69%, 
with a mean of 39%, compared to a mean of 51% for 
normals (P < 0.2). At a 25:1 E:T cell ratio; diabetic 
patients demonstrated a mean of 29% NK activity, 
compared to 37% cytotoxicity manifested by norm- 
als (P < 0.2). At I0:1 and 5:1 E:T cell ratios, 
diabetic patients demonstrated a mean of 20 and 
13% NK activity, respectively, compared to a mean 
of 19 (P < 0.2) and 12% (P < 0.2), by normals. One 
of two prediabetic patients demonstrated increased 
NK activities of 69, 60, 44, and 25% at 50:1, 25:1, 
10:1, and 5:1 ET cell ratios, respectively. Figure 1B 
shows that 10 diabetic patients demonstrated a 
mean of 24, 17, 12, and 9% ADCC activity, com- 
pared to 39 (P < 0.2), 29 (P < 0.2), 23 (P < 0.2), and 
10% (P < 0.1) shown by 10 normals at 50:1, 25:1, 
10:1, and 5:1 E:T cell ratios, respectively. One of 
two prediabetic patients also showed increased 
ADCC activity compared to controls at all E:T cell 
ratios. In summary, only 2 of 11 IDDM patients 
manifested markedly lower levels of NK activity (3 
and 12% killing), while 2 other IDDM patients 
demonstrated decreased levels of ADCC activity (1 
and 5% killing) at 50:1 E:T cell ratios. A similar 
pattern of reduced NK and ADCC activities was 
observed at other E:T cell ratios for these two 
patients. These data demonstrate that NK and 
ADCC activities of lymphocytes from IDDM pa- 
tients are comparable to those of normals. 
Lectin-Dependent Cellular Cytotoxicity of lDDM 
Lymphocytes 
Since the majority of IDDM lymphocytes demon- 
strated normal levels of NK and ADCC activities, 
we investigated whether they could be further acti- 
vated by lectin. Data presented in Table I demon- 
strate that normal lymphocytes produced signifi- 
cantly increased cytotoxicity, against nonsensitive 
NK targets, SB cells, at all PHA concentrations, 
compared to negligible cytotoxicity in the absence 
of PHA. Diabetic lymphocytes exhibited a 
cytotoxicity of 2% without PHA, which was signifi- 
cantly enhanced by the addition of PHA. It is inter- 
esting to note that one prediabetic patient produced 
21% spontaneous cytotoxicity against the usually in- 
sensitive SB target cells, which was further enhanced 
with varying concentrations of PHA. The second 
prediabetic patient showed enhancement of cytotox- 
icity with PHA comparable to that of diabetic lym- 
phocytes. These data suggest that the percentage 
enhancement of cytotoxicity by PHA was comparable 
in diabetics and controls, although a greater than 
normal enhancement of LDCC was demonstrated in 
one of two prediabetic patients. 
In Vitro Effect of Glucose and Insulin on the NK 
Activity of Normal Lymphocytes 
To investigate whether the poor gtycemic control 
often seen at diagnosis of IDDM patients could also 
influence the cytotoxic activities of their lympho- 
cytes, PBL from normal donors preincubated for 24 
hr with varying concentrations of glucose were 
examined for NK activity. Data presented in Table 
II demonstrate that a range of glucose concentra- 
tions did not show any effect on the NK activity of 
normal lymphocytes. We also examined whether 
insulin could modulate the cytotoxic functions of 
normal lymphocytes (Table III). These results dem- 
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Fig. 1. (A) NK activity of lymphocytes from patients with IDDM and prediabetes, Effector cells were depleted of 
phagocytic cells and K562 targets were labeled with SlCr as detailed in Materials and Methods. A, IDDM patients; A, 
prediabetic patients. The shaded area is the range of control cells and horizontal lines define the mean -+ SD of the patient 
values. (B) ADCC activity of lymphocytes from patients with IDDM and prediabetes. Effector cells were depleted of 
phagocytic ceils and antibody-coated SB target cells were labeled with 51Cr as detailed in Materials and Methods. A, 
IDDM patients; A, prediabetic patients. The shaded area is the range of control cells and horizontal lines define the mean 
-+ SD of the patient values. 
onstrate that lymphocytes precultured with varying 
concentrations of pork insulin showed a moderate 
enhancement of their NK activity compared to 
control lymphocytes. 
Effect of  lFN and IL2 on NK Activity of lDDM 
Lymphocytes 
P B L  f rom I D D M  patients  and normal  donors 
were examined for the ability of IFN or IL2 to 
enhance cytotoxicity against K562 tumor target 
cells. Data presented in Fig. 2, representing the 
mean -+ SD of four separate experiments performed 
in triplicate, demonstrate that PBL from IDDM 
patients precu!tured with IFN or IL2 showed sig- 
nificantly more enhancement of their cytotoxicity, 
compared to lower IFN- or IL2-induced enhance- 
ment of the NK activity of normal lymphocytes. 
Viability of IDDM lymphocytes precultured with 
IFN or IL2 was >85%, comparable with that of 
similarly treated control cultures as assessed by 
trypan blue dye exclusion. 
Suppression of" NK Activity of Fresh Lymphocytes 
by Lymphocytes Precultured with Con A 
We studied the effect of preculturing total PBMC 
with and without Con A to induce suppressor cells. 
Table I0 Effect of Lectin on Cellular Cytotoxicity of Lymphocytes ~ 
Lymphocyte % cytotoxicity b at PHA concentration 0xg/ml) 
source 0 1 2.5 5 
Normals (N = 5) 4.7 -+ 0.8 c 26.1 +- 11,1 (455) a 26,5 -+ 9.4 (463) 25.4 - 11.1 (440) 
P < 0.05 e P < 0.025 P < 0.05 
Diabetics (N = 5) 2.2 -+ 0.4 15.t + 5.2 (587) 14,1 -+ 6.1 (540) 20.7 --- 8.6 (840) 
P < 0.025 P < 0,05 P < 0,05 
Prediabetics s 
No. 1 20.8 40.1 (92) 41.4 (88) 36.5 (75) 
No, 2 1.6 I5.4 (862) 18.1 (1031) 12.3 (668) 
"The lectin-dependent cellular cytotoxicity (LDCC) assay was carried out similarly to the NK assay except the NK-resistant SB cell line 
was used as targets. Effector cells were depleted of adherent cells and targets were labeled with 5~Cr. 
bCytotoxicity was calculated as described in Materials and Methods. 
Walues represent mean percentage cytotoxicity -+ SD of five separate experiments performed in triplicate at a 50: t E:T cell ratio. 
dData in parentheses indicate the percentage enhancement of cytotoxicity. 
~Statistical values were determined by a single-tail Student's t test. 
SIslet-cell antibody-positive patients without overt disease. 
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Table II, Effect of Glucose on NK Activity of Normal 
Lymphocytes in vitro a 
Glucose concentration NK reactivity b 
(mg/dl) (lytic units/107 effector cells) 






~Effector PBL (2 x 106/ml) depleted of adherent cells were 
precultured with varying concentrations of glucose for 24 hr, 
washed, and tested tbr NK activity as described in Materials 
and Methods. 
bCytotoxicity was calculated as lytic units per 10 7 effector cells 
as described in Materials and Methods. 
CValues represent the mean of triplicate determinations of a 
representative experiment. Three other experiments produced 
similar results, 
Data presented in Fig. 3 show that normal PBMC 
precultured with 30 Ixg Con A/ml displayed signifi- 
cantly lower levels of NK activity than manifested 
by PBMC precultured in medium alone. In contrast, 
PBMC from diabetic patients precultured with Con 
A did not exhibit any significant inhibition of 
cytotoxicity compared to patients' cells in the ab- 
sence of Con A. The failure of Con A to reduce the 
cytotoxicity of patients' PBMC to levels compara- 
ble to those of healthy donors suggests a potential 
defect in the generation of Con A-inducible sup- 
pressor cells in IDDM. Results presented in Table 
IV demonstrate that normal donor lymphocytes 
precultured with Con A suppressed the cytotoxicity 
of allogeneic normal lymphocytes. Lymphocytes 
from three of five diabetic patients precultured with 
Con A showed diminished suppression of the NK 
activity of fresh normal, allogeneic lymphocytes. 
PBL from both prediabetic patients precultured 
with Con A, however, showed marked inhibition of 
the NK activity of normal lymphocytes. 
D I S C U S S I O N  
Because of the role of autoimmune mechanisms 
in the pathogenesis of IDDM, analysis of the im- 
mune status of diabetic patients may be of signifi- 
cance in understanding the disease process. Recent 
evidence suggests that NK and ADCC reactions are 
important in the regulation of various immunologi- 
cal reactions, in addition to their proposed role in 
immune surveillance against tumors and virus-in- 
fected cells (9-11). Several studies on the immuno- 
logic activities of lymphocytes from IDDM patients 
have yielded conflicting results (17-19). Huang and 
MacLaren (7) showed an enhanced cytoadherence 
and cytotoxicity of IDDM lymphocytes to 
insulinoma cells, and Pozzilli et al (21) and Sensi et 
al. (6) demonstrated an increased number of low- 
affinity sheep erythrocyte rosette-forming cells in 
IDDM. In an extensive analysis using a xenogenic 
system Charles et aI. (22) demonstrated that PBL 
from IDDM patients showed cell-mediated 
cytotoxicity against rat islet-cell targets. Harold et  
al. (23) and Chandy et al. (24) have reported a 
decreased level of circulating Leu 7 + cells in newly 
diagnosed type I disease. Kohler et al. (25) ob- 
served that 46% of newly diagnosed patients' sera 
supported ADCC activity against pancreatic islet 
cells. A marked reduction of T3, T4, T8, and M1 
antigen expression on the lymphocytes of newly 
diagnosed IDDM patients compared to patients 
with long-standing disease has been reported (26). 
The results of the experiments described herein 
demonstrate that, in general, lymphocytes from 
IDDM patients express NK and ADCC activities 
comparable to those of matched normal controls 
(Figs. 1A and B). The wide variation of NK and 
ADCC activities observed in diabetic patients may 
be associated with heterogeneity of disease includ- 
ing duration, genetic profile, insulin response, etc. 
It is interesting to note that one of two patients with 
prediabetes who were seropositive for ICA demon- 
strated increased NK and ADCC activities, sug- 
gesting that dysfunction of immune surveillance 
mechanisms may occur during the period preceding 
clinical onset of the disease. 
It has been previously demonstrated that lympho- 
cyte cytotoxicity can be activated by lectin. The 
exact function of lectin activation is not presently 
understood, but it has been suggested that it may 
act directly on cytotoxic cells by rearranging recep- 
tors for recognition sites on target cells or providing 
sufficient signals to trigger subsequent lytic events 
(27, 28). In this report the percentage enhancement 
of LDCC in diabetic patients is similar to that in 
normals (Table I). However, the increased basal 
cytotoxicity of lymphocytes from one prediabetic 
patient against SB targets, which are not sensitive 
to NK activity, could be a manifestation of the 
prodrome of IDDM. A more comprehensive assess- 
ment of immune function should be undertaken in 
diabetes. 
Recently it has been demonstrated that insulin 
may be associated with immunostimulation. 
Helderman and Raskin (29) found a comparable 
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Table III. In vitro Effect of Insulin on the NK Activity of Normal T Lymphocytes ~ 
Insulin Cytotoxicityb: experiment No. 
concentration 
(txU/mI) 1 2 3 4 
0 t9.2 ~ 25.6 39.4 31.0 
100 29.8 (55.2) d 34.4 (34.3) 53.8 (36.5) 57.0 (83.8) 
25 29.2 (52.0) 36.5 (42.5) 53.2 (34.0) 55.5 (79.0) 
10 26.1 (35.9) 34.6 (35.1) 51.2 (29.9) 53,9 (73.8) 
1 35.4 (84.3) 36,3 (41.7) 51.0 (29.4) ND ~ 
0.1 27.5 (43.2) 33.5 (30.8) 50.4 (27.9) ND 
~2 x 106 T cells/ml were precultured with pork insulin for 24 hr, washed, and tested for NK activity 
at a 20:1 E:T cell ratio. The viability of treated lymphocytes was 78%, comparable to that of 
control ceils. 
bCytotoxicity was calculated as described in Materials and Methods. 
cValues represent the mean percentage cytotoxicity of triplicate determinations. 
'tValues in parantheses represent the percentage enhancement of cytotoxicity compared to control 
cells. 
~Not done. 
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Fig. 2. Effect of interferon and interleukin.2 on the NK activity of 
lymphocytes from diabetics and normals. PBL depleted of adherent 
cells were precultured for 24 hr with 250 U of IFN or 64 U/ml of 
IL2, previously found to yield the maximum NK augmenting effect. 
Washed PBL were tested for NK activity against prelabeled K562 
target cells at a 50:1 E:T cell ratir. Enhancement of NK activity by 
IFN or IL2 treatment of lymphocytes was calculated in comparison 
with untreated control lymphocytes. The statistical significance of 
differences was determined using a single-tail Student t test. 
t ro is .  I t  was  a lso  s h o w n  tha t  insul in  a u g m e n t s  the  
m e t a b o l i s m  o f  a c t i v a t e d  T cel ls  in a ra t  m o d e l  (30). 
The  resu l t s  r e p o r t e d  he re in  d e m o n s t r a t e  tha t  insul in  
m a y  h a v e  s o m e  s t i m u l a t o r y  ef fec t  on  the  c y t o t o x i c  
ac t iv i ty  o f  p r e c u l t u r e d  n o r m a l  l y m p h o c y t e s  (Tab le  
III) .  E n h a n c e m e n t  o f  c y t o t o x i c i t y  b y  e x o g e n o u s  
insul in  m a y  pa r t i a l l y  e x p l a i n  the  p a r a d o x i c a l  o b s e r -  
va t i on  o f  n o r m a l  N K  func t ion  b y  I D D M  t y m p h o -  
c y t e s  in spi te  o f  d e c r e a s e d  L e u  7- and  T 8 - p o s i t i v e  
l y m p h o c y t e s  as r e p o r t e d  b y  o the r s  (23, 24, 26, 31). 
S ince  T l y m p h o c y t e s  can  a lso  e x p r e s s  N K - l i k e  
c y t o t o x i c i t y  aga ins t  K562 t a rge t s ,  this  effect  o f  
insul in  m a y  be  due  to r e c r u i t m e n t  o f  f u n c t i o n a l l y  
N K  r e a c t i v e  cel ls  f rom the  T-ce l l  p o p u l a t i o n .  Ex-  
p e r i m e n t s  us ing  pur i f ied  H N K 1  + o r  L e u  7 + m o n o -  
4.0- 











Fig. 3. NK activity of Con A-activated lymphocytes. Total mono- 
nuclear cells from both control and IDDM patients were cultured 
with and without 30 txg Con A/ml for 48 hr. Values represent the 
mean cytotoxicity --- SD of four separate experiments, with tripli- 
cate determinations for each at an E:T cell ratio of 50:1. The 
statistical significance of differences was calculated using a single- 
tail Student t test. 
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Table IV. Suppression of NK Activity of Normal 
Lymphocytes by Lymphocytes Precultured with Con A" 
Source of Con A- % 
treated PBL suppression b 
Normals 












17.0 + 18.7 




55.2 - 12.! 
(P < 0.25) 
q n  mixing experiments to measure suppressor-cell activity, PBL 
precultured with or without Con A were added separately to a 
mixture of effector and 51Cr-labeled K562 target cells. 
°Suppression was calculated as described in Materials and 
Methods. 
cValues represent the mean percentage suppression of triplicate 
determinations of each sample. 
qslet-cell antibody-positive patients without overt disease. 
nuclear cells and isolated T cells may resolve this 
issue, although HNK1 + cells represent only a small 
proportion of NK cells. IFN and IL2 seem to have 
a major role in immunoregulation (32, 33) and in 
augmentation of NK activity both in vitro and in 
vivo (33, 34). IFN may enhance NK activity by 
several mechanisms including stimulation of 
noncytotoxic pre-NK cells to mature cytotoxic ef- 
fector cells (35) and activation of mature NK cells 
that are transiently inactive (36). Alternatively, IFN 
may potentiate endogenous lyric mechanisms by 
inducing the development of new receptors or mod- 
ulating preexisting effector-cell surface receptors or 
their avidity (35-37). It has also been shown that 
IL2 can induce IFN; this has been used successfully 
in the establishment of NK clones (37). Recently 
Svedersky et al. (39) reported that augmentation of 
NK activity by !L2 and IFN involves overlapping 
mechanisms. Hayward and Herbenger (40) demon- 
strated that lymphocytes from IDDM patients had 
increased numbers of IL2 receptor-positive cells. 
Chandy et al. (41) showed that exogenous IL2 
reversed the AMLC reaction in diabetics, whereas 
Zier et al. (42) demonstrated decreased synthesis of 
IL2 by diabetic lymphocytes. Consistent with these 
observations our data further demonstrate that lym- 
phocytes from patients with IDDM show increased 
enhancement of cytotoxicity when stimulated with 
IL2 and IFN, in contrast to PBL from healthy 
donors. Thus although lymphocytes from IDDM 
patients may produce less IL2 than control cells, 
they may be more responsive to lower endogenous 
levels of IL2, possibly through the greater propor- 
tion of circulating IL2 receptor-bearing cells as 
compared with healthy controls. We have earlier 
reported that unstimulated cultured normal human 
lymphocytes can develop suppressor-cell activities 
against NK and ADCC reactions as a possible 
consequence of an AMLC (17). This suppressor- 
cell activity could be further enhanced by precultur- 
ing lymphocytes with Con A. Previous studies have 
shown that IDDM patients demonstrate reduced 
antigen-specific or nonspecific suppressor-cell ac- 
tivities in vitro as measured by the lymphocyte 
proliferative response to mitogen and alloantigens 
(43-45). Although preculture of lymphocytes from 
IDDM patients or controls with Con A results in 
diminished NK activity, treated PBL from diabetics 
demonstrated persistently higher NK activity than 
controls. This observation is consistent with the 
premise that Con A was not as effective in inducing 
suppressor activity in PBL from IDDM patients as 
it was with normal lymphocytes. To confirm this, 
mixing experiments utilizing Con A-pretreated lym- 
phocytes were undertaken. Our results indeed dem- 
onstrated a deficiency of Con A-inducible suppres- 
sor cells using lymphocytes from IDDM patients. 
Because of the increasing evidence that cytotoxic 
cells may be involved in the destruction of pancre- 
atic beta cells, an analysis of the interplay between 
activated suppressor cells and NK cells may further 
elucidate the immunopathogenesis of IDDM. 
Diminished suppressor-cell functions associated 
with IDDM may explain, in part, the escape of 
cytotoxic activities from normal immunoregulatory 
mechanisms resulting in islet-cell destruction. The 
paradoxical observation of increased NK activity 
associated with the prediabetic state may be a 
manifestation of normal immunologic antiviral sur- 
veillance, especially if one considers a possible viral 
etiology for IDDM. Thus suppressor-cell activation 
might counteract progressive destruction of 
uninfected islet cells after elimination of any puta- 
tive initial infection. Failure of suppressor-cell ac- 
tivation could ultimately result in total islet-cell 
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destruction and IDDM, Moreover, cytotoxicity 
may be further stimulated by an increased sensitiv- 
ity to IFN and IL2 as our data suggest. 
The studies reported herein using tumor-cell tar- 
gets are our initial investigations examining 
cytotoxic activities in IDDM. Further experiments 
using pancreatic islet-cell targets will attempt to 
address the specificity of these observations. In 
summary, however, it appears that IDDM may be 
associated with an increased sensitivity of cytotoxic 
cells to enhancement with IFN and IL2 and de- 
creased suppressor-cell activity. These immuno- 
logic mechanisms may play a role in the pathogen- 
esis of the disease. 
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